Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Randomized, Placebo-controlled Phase IV Clinical Study of the Efficacy and Safety of a New Formulation of Paracetamol for the Management of Fever of Infectious Origin

NCT02283203 is registered in ClinicalTrials.gov with Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. as lead sponsor.

NCT NCT02283203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02283203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Randomized, Placebo-controlled Phase IV Clinical Study of the Efficacy and Safety of a New Formulation of Paracetamol for the Management of Fever of Infectious Origin
Lead sponsor
Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2015
Completion date
March 31, 2016
Enrollment
80 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

fever